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PKR Protein Kinase R 
dsRNA double-stranded RNA 
dsRBD double-stranded RNA binding domain 
dsRBM1 double-stranded RNA binding motif 1 
dsRBM2 double-stranded RNA binding motif 2 
eIF2α eukaryotic initiation factor 2α 
unPKR unphosphorylated PKR 
pPKRm phosphorylated monomeric PKR 
pPKRd phosphorylated dimeric PKR 
Kd dissociation constant 
LB Luria-Bertani Broth 
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EDTA ethylenediaminetetraacetic acid 
BME β-mercaptoethanol 
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PVDF polyvinylidene difluoride
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Abstract 
 
Protein Kinase R (PKR) is induced by interferon and activated by dsRNA.  Subsequent 
autophosphorylation and phosphorylation of eIF2α inhibits viral replication.  In the latent 
state PKR exists as an unphosphorylated monomer.  Work in the Cole laboratory has 
shown two additional states, a phosphorylated monomeric state (pPKRm) and a 
phosphorylated dimeric state (pPKRd).  RNA serves as a scaffold bringing two PKRs 
together allowing dimerization and autophosphorylation to occur.  The contribution of 
each state to the function of PKR remains unclear.  Western blots were performed to 
examine the phosphorylation states of the essential residues, T446 and T451.  Activity 
assays have shown activation of pPKRm at a level comparable to pPKRd in its ability to 
phosphorylate eIF2α.  Phosphorylation of eIF2α by both pPKRm and pPKRd was shown 
to be RNA independent.  Despite reaching similar terminal levels of eIF2α 
phosphorylation, kinetic measurements revealed a faster reaction from pPKRd.  
Therefore, pPKRm and pPKRd may both contribute to the activity of PKR. 
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Introduction 
 
Kinases are the enzymes which catalyze phosphorylation reactions, the movement 
of a phosphate group from a nucleotide triphosphate to another molecule.  In protein 
kinases, the other molecule is a protein, and the phosphate is transferred to specific amino 
acid side chains.  The amino acids that are usually phosphorylated are serine, threonine, 
or tyrosine residues, all of which are relatively small and have a free hydroxyl group (p. 
229) [1]. 
  The functional diversity of proteins is enhanced by post-translational 
modifications.  These alterations can change the shape, the intramolecular and 
intermolecular interactions, and the destination of the protein.  Phosphorylation is the 
most common covalent post-translational modification. When a specific amino acid 
residue becomes phosphorylated, the double negative charge of the phosphate can induce 
conformational change by hydrogen bonding or by creating a salt bridge to a positively 
charged residue.  The three dimensional conformation of proteins, in which amino acids 
far apart in the linear secondary structure are brought close together by the folding of the 
protein enables the newly-bound phosphates to form linkages with amino acid residues 
far away, thus enabling drastic conformational change.  The conformational change can 
block or change the substrate binding pocket and ultimately change the activation state of 
the enzyme.  Therefore, protein kinases are responsible for the activation or inactivation 
of an enzyme [2]. 
 Protein kinases are known as switch proteins for their characteristic control of 
activation.  Several protein kinases have been studied and identified for their integral role 
in the activation or inactivation of transcription, translation, gene expression and 
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signaling.  A specific protein kinase that regulates translation is Protein Kinase R (PKR). 
Once activated by dsRNA PKR inhibits eIF2α, a eukaryotic initiation factor.  
Phosphorylation of serine 51 on the alpha subunit of eIF2α inhibits the formation of the 
initiator Met-tRNA/GTP/eIF2 complex.  Without the formation of this complex, initiator 
Met-tRNA cannot bind to the ribosome and translation is inhibited [3].  Therefore, the 
activation of PKR, and subsequent phosphorylation of eIF2α halts viral replication.  
Since the main source of dsRNA, the primary PKR activator, is a virus this pathway is a 
prime candidate for pharmaceutical antiviral therapy. 
 Human PKR is a 62 kDa enzyme. At its N-terminal side, PKR contains a 20 kDa 
N-terminal double stranded RNA binding domain (dsRBD).  The domain is composed of 
two double stranded RNA binding motifs (dsRBM1and dsRBM2) joined by a 22 amino 
acid flexible linker.  Each of these dsRBMs are composed of an αβββα fold in which the 
alpha helices lie together in one plane next to the plane of the antiparallel beta sheet [4]. 
Positively charged amino acid residues on the surface of each of the dsRBMs create the 
opportunity for RNA binding. Although close examination of the dsRBD yielded no 
cooperatively between the dsRBMs, they both bind dsRNA [5] [6].   
  The kinase domain is located in the C-terminal region of PKR.  It contains the 
amino acid residues which need to be phosphorylated in order for activation to occur [6] 
and is the site of dimerization [7].  The kinase domain itself has characteristic structure at 
the N-lobe and C-lobe.  The N-lobe is composed of a five-stranded anti-parallel beta 
sheet, with one alpha helix on the side and another on the top.  The C-lobe is composed 
of two antiparallel beta strands and eight alpha helices, between which the 
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phosphoregulatory stretch of activation residues, are located. Additionally, the C-lobe is 
the site of eIF2α binding [7]. 
 In the 551 amino acids that compose PKR, there are 15 known phosphorylation 
sites occurring in clusters along PKR (Figure 1).  The functional kinase domain contains 
two important phosphorylation sites, one on Threonine 446 [8][7] and another on 
Threonine 451[8][9].  The phosphorylation of these two sites is essential to activity, 
which has been shown by complete inactivation with mutation [8, 10]. Mutation of the 
serine and threonine residues in the linker region of the kinase has been tested in yeast, 
and no effect has been observed[9].  No effect on activity from the mutation of the 
phosphorylated residues in the linker region between dsRBM1 and dsRBM2 has been 
observed either [9-11].  Therefore, the threonine residues at positions 446 and 451 are 
most relevant for an understanding of activation. 
 
Figure 1. Phosphorylation sites of PKR.  All of the known phosphorylation sites in PKR 
are represented.  The sites in red are critical to PKR function.  The site in blue may be 
involved in activity.  The sites in magenta and green do not affect PKR function.  
 
 The current proposed mechanism for PKR activation is the dimerization model.  
PKR has been found to be capable of existing as a dimer when phosphorylated[12, 13].  
The binding of two PKR molecules to dsRNA causes dimerization and a conformational 
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change stabilizing the dimer [14].  ATP then binds to PKR allowing autophosphorylation 
[6].  Once autophosphorylated, PKR can phosphorylate eIF2α, preventing translation 
initiation from occurring [6]. 
 PKR exists in a weak monomer-dimer equilibrium [13].  The existence of two 
distinct phosphorylated monomeric (pPKRm) and phosphorylated dimeric (pPKRd) 
populations has been defined by column elution, mass spectrometry, isoelectric focusing 
and analytical centrifugation (Anderson and Cole, unpublished data).  The size exclusion 
column elution profile showed two distinct populations; a monomeric population and a 
dimeric population.  Overnight equilibration and reapplication of the fractions of each 
population to the column indicated little inter-conversion (Anderson and Cole, 
unpublished data).  Mass spectrometry showed pPKRd had an average of 10 phosphates 
while pPKRm averaged about 9, which was supported by a higher pI of pPKRd 
indicating a greater level of phosphorylation.  Both mass spectrometry and isoelectric 
focusing showed that pPKRm and pPKRd exist in heterogeneous phosphorylation states 
in which some enzymes are more phosphorylated than others.  Analytical 
ultracentrifugation showed the Kd for the self association pPKRm to be 450 uM and the 
Kd for the self association of pPKRd to be 0.95 uM [13].  However, the difference in the 
origin and purpose of the two phosphorylated forms of PKR remains unclear.   In the 
present hypothesis, the order in which the phosphorylation sites become activated must 
occur sequentially in that order for dimerization to occur.  In the monomer, the order was 
perturbed and the enzyme hit a dead end on the path to dimerization. 
 The characterization of the phosphorylated monomer and dimer forms of PKR 
can aid in deciphering the mechanism of activation of PKR.  Activation assays, in which 
  
11 
ATP, the phosphate donor, radiolabeled with 32 P is used to quantify the activity of 
specific samples.  Using this technique, the relative amount of activation in the monomer 
or dimer form of PKR can be assessed under different conditions.  The control for this 
experiments is unphosphorylated PKR.  Unphosphorylated PKR should show no initial 
activation in the absence of dsRNA..   
 When viruses invade a cell, the interferon system is activated, which induces the 
transcription of a large number of antiviral genes, including PKR.   Interferon is involved 
in specific stages of antiviral response, even prior to the adaptive immunity response. It 
has been shown that mice lacking interferon are susceptible to a greater number of viral 
infections [15].  The study of PKR is important because interferon is a poor candidate for 
viral targeting due to involvement in numerous signaling pathways.  Many other 
pathways would be unnecessarily activated, resulting in unnecessary side-effects.  
Therefore a detailed understanding of how PKR functions would be useful to generate a 
more specific clinical antiviral treatment.  A primary aspect of function is activation, and 
the proposed project examines the key differences in the activation of the phosphorylated 
monomer and dimer forms.  Understanding the phosphorylation events which lead to the 
separate occurrence of monomer and dimer populations can lead to a deeper 
understanding of activation, and in turn methods of antiviral treatment. 
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Materials and Methods 
 
M.1 PKR Expression 
A glycerol stock of the PKR expression plasmid pPKR/pPase in Rosetta DE3 plys 
S cells was streaked onto a carbenicillin and chloramphenicol agar plate and incubated 
inverted at 37°C for 24 hours.  Isolated colonies were chosen and each was placed into 10 
mL of autoclaved LB media containing 10 uL 50 mg/mL carbenicillin, and 10 uL 34 
mg/mL chloramphenicol, and then placed in the shaking incubator overnight at 37°C.  All 
cloudy cultures were combined, and 3 mL were added to each of 8 flasks containing 750 
mL autoclaved LB, 750 uL carbenicillin, and 750 uL chloramphenicol.  A random sample 
was taken to be used as a blank and the spectrophotometer was blanked at 600 nm.  All 
flasks were placed in the shaking incubator at 37°C and the absorbance of each flask was 
measured every thirty minutes until the optical density at 600 nm reached 0.7.  Then, the 
flasks were swirled over ice until they reached 18°C and 750 uL of 1M IPTG was added 
to each flask.  The flasks then returned to the incubator and swirled at 15°C with the lid 
open for approximately three hours.  The flasks were removed from the shaking 
incubator.  The 6 liters of culture was removed from the flasks and centrifuged in 1L 
bottles in the Sorval Evolution Centrifuge at 8K RPM for 10 minutes.  The centrifugation 
process was repeated with the remaining culture in the same 1L bottles.  After 
centrifugation the supernatant was discarded and the pellet was stored in a 50 mL falcon 
tube in the -80°C freezer. 
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M.2 PKR Purification 
 The pellet from M.1 was thawed on ice and resuspended with 1.2 mL of Sigma 
protease inhibitor cocktail, P8465, and 15 mL Buffer A (20 mM HEPES, 50 mM NaCl, 
0.1 mM EDTA, 10% glycerol, 10 mM BME added just before use, pH 7.5). Sonication 
with a Fisher Scientific Sonic Dismembrator, Model 100, was performed at 80% power 
on ice for 40 seconds with 1 minute and 20 seconds rest and was repeated six times. The 
lysate was centrifuged at 22,000g for 20 minutes.  The pellet was resuspended in 15 mL 
of Buffer A and the six sonication steps and centrifugation was repeated as above.  The 
first and second supernatants were combined, and centrifuged at 22,000 for 20 minutes.  
The pellet was properly disposed and the final supernatant was saved for the heparin 
column.   
The heparin column was equilibrated in 50% Buffer A and 50% Buffer B (20 mM 
HEPES, 1.2 M NaCl, 0.1 mM EDTA, 10% glycerol, 10 mM BME added just before use, 
pH 7.5).  The column was equilibrated to 90% Buffer A and 10% Buffer B.  The 
supernatant was loaded onto the column.  The column was washed with a 150 ml Buffer 
B gradient and eluted using a 90 ml gradient from 20 to 80 % B. The fractions in the 
middle of the peak were pooled and applied to the AG-PolyrI:rC Column.  The AG-
PolyrI:rC Column was washed with Buffer C (20 mM HEPES, 2.0 M NaCl, 0.1 mM 
EDTA, 10mM BME, 10% glycerol, 10mM BME added just before use, pH 7.5) and then 
equilibrated with 80% Buffer A and 20% Buffer C.  The column was washed with a 390 
Buffer B gradient and eluted using a 120 ml gradient from 50 to 80 % B.  The selected 
fractions from the heparin column were pooled and applied to the AG-PolyrI:rC Column.  
The inner fractions were saved for the gel filtration column.  
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 A Superdex 200 gel filtration column was equilibrated with AU200 buffer (20 
mM HEPES, 200 mM NaCl, 0.1 mM EDTA, 0.1mM TCEP added just before use, pH 
7.5.).  The peak fractions from the AG-PolyrI:rC column were applied using a syringe to 
the gel filtration column.  The column was washed with a 200 ml Buffer B gradient and 
eluted using a 170 ml gradient from 50 to 100 % B. The peak fractions were pooled and 
stored at 4°C. 
 
M.3 SDS PAGE Gel Electrophoresis 
            For each sample, 10 uL containing 5 ug of protein was mixed with 6 uL 4x LDS 
sample buffer.  10 uL/well were loaded onto a Novex pre-cast 4%-12% polyacrylamide 
Bis-Tris NuPage gel.  MOPS buffer was used. The gel was electrophoresed at 200V for 
50 minutes.  The gel was stained in 10% acetic acid, 40% methanol, 50% water, and 
0.25% Coomassie brilliant blue.  After stain was added, the gel in the stain was 
microwaved for 2 minutes and shaken at room temperature for 10 minutes.  The gel was 
incubated in destain  (10% acetic acid, 40% methanol, 50% water), microwaved for 2 
minutes and then shaken for 10 minutes.  The destain process was repeated until the 
bands on the gel could be clearly visualized.  Finally, the mixture was left on the shaker 
with 3 kim wipes until most of the purple had left the gel.  The gel was sandwiched 
between two pieces of parafilm and a picture was taken in the scanner. 
 
M.4 Western Blots 
 An SDS-PAGE gel was run then transferred to a PVDF Immobilon-FL membrane 
with a pore size of 0.45um.  The transfer was performed in Transfer Buffer (12mM Tris 
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base, 96mM glycine).  Blotting pads and filter paper were soaked in transfer buffer, (20% 
methanol, 76% distilled water) for 15 minutes.  The same was done for the membranes, 
except that they were first rinsed in methanol.  From bottom to top a sandwich of two 
blotting pads, filter paper, the gel, the transfer membrane, filter paper and two more 
blotting pads was constructed in the XCell II Blot Module.  The transfer ran overnight in 
the cold room at 15V.  The WesternBreeze Chromogenic Immunodetection Kit was used 
to develop the bands.  The kit contained Blocker/Dilutent A, a concentrated buffered 
saline solution with detergent and Blocker/Diltuent B, a concentrated Hammersten casein 
solution.  First, the membrane was rinsed with blocking solution (20%A, 30%B) for 30 
minutes on the rotary shaker, then rinsed with water twice.  The membrane was rinsed in 
primary antibody Solution (20% A, 10% B, antibody) for one hour on the rotary shaker.  
After rinsing 4 times for 5 minutes with antibody wash (buffered saline solution with 
detergent) the membrane was rinsed with secondary antibody solution (alkaline 
phosphatase-conjugated, affinity purified, goat anti-Rabbit) for 30 minutes.  Four rinses 
with antibody wash for 5 minutes were performed, followed by three 2 minute rinses with 
water.  The membranes were incubated with BCIP/NBT chromogenic substrate until 
bands were visible.  Finally the membrane was rinsed three times for 2 minutes in water 
and the membranes were left to dry in the hood overnight. 
 Antibodies from two different sources were utilized.  First, the following 
antibodies were obtained from SignalWay: PKR (Ab-446), PKR (Phospho-Thr446), and 
PKR(Ab-451).   Next, antibodies previously purchased and successfully utilized by the 
lab were used.  These antibodies were anti-PKR, anti-phospho-T451 and anti-phospho-
  
16 
T446 from Cell Signaling Technologies.  Cell Signaling Technologies no longer makes 
these antibodies, therefore the antibodies were over two years old. 
 
M.5 Autophosphorylation Assays 
 Assays contained 100 nM PKR, 0.4 ug eIF2α, polyrI:rC and P50 Buffer (20 mM 
HEPES, 50 mM KCl,  5 mM MgCl2, 0.1 mM TCEP, pH 7.5) in a final volume of 16 uL.  
The samples and stop buffer were equilibrated for 10 minutes at 32°C.  Stop buffer 
contained 108 uL 4x LDS and 44 uL BME.  An ATP mix containing both the radioactive 
and regular ATP was created.  The ATP mix was added to each sample so that 1uCi was 
present in each of the reaction tubes.  If a kinetic experiment was not being performed, 
the reactions ran 20 minutes and the samples were quenched with stop buffer and heated 
at 70°C for 10 minutes.  The samples were analyzed by SDS-PAGE using 12 uL/well in a 
12% NuPage gel at 200V for 75 minutes.  After being fixed in destain (10% acetic acid, 
40% methanol, 50% water) for 30 minutes the gel was rinsed in water for 15 minutes and 
equilibrated in gel dry solution (4% glycerol, 20 % ethanol, 76% water) for 30 minutes.  
The drying membranes were rinsed in gel dry solution for 1 minute, and the gel was 
placed between the membranes and dried overnight.   
 The gel was visualized by exposure to a blanked phosphor screen for about an 
hour and then quantified using a Biorad PMI Phosphorimager with the QuantityOne 
software.  Three blank boxes and boxes around each band were made of the exact same 
size.  The average of the blank boxes was manually subtracted off the raw intensity value 
of each band.  The data was imported into Excel and graphed in KaleidaGraph.  The data 
was fit to the exponential growth curve option in KaleidaGraph.  Because eIF2α has one 
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phosphorylation site, the average of the eIF2α intensity was used to obtain the average 
number of phosphates incorporated into PKR.   
 
M.6 DNA Gel Electrophoresis 
 A 1% agarose gel was cast in TAE Buffer (Stored at 20X, 96.8g  Tris Base, 22.84 
ml glacial acetic acid, 40 ml 0.5M EDTA).  The mixture was microwaved until the 
powder was fully melted and in solution.  Once the agarose mixture had cooled to 60°C it 
was poured into the gel tray and a comb was added.  After the gel cooled, the tray was 
rotated 90°.  Loading dye was added to the samples in a 1:5 ratio, and the wells were 
loaded with 10-30 uL of sample.  Gels were run at 100V for 90 minutes.  The gels were 
stained with 150 mL water and 5% ethidium bromide on the shaker for 15 minutes.  A 
water rinse was performed twice on the shaker for 15 minutes to remove excess ethidium 
bromide.  DNA bands were imaged using a UV transilluminator and photographed in Dr. 
Robinson's laboratory. 
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Results 
 
Western Blots 
Western blots were performed to determine whether pPKRm and pPKRd were 
phosphorylated on the essential residues T446 and T451.  An initial western blot using 
PKR-T446 and phospho-PKR-T446 antibodies from Signal Way was first analyzed.  In 
the PKR-T446 treated blot a larger band was seen for the dimer, and the bands for 
unPKR and pPKRm appeared to be background noise.  The PKR-T446 antibody should 
recognize those forms of PKR that are not phosphorylated at T446, and should show the 
strongest band for unphosphorylated PKR, therefore it was determined that the antibody 
was faulty.  The phospho-PKR-T446 blot looked correct, with the most intense bands for 
pPKRd, smaller for the pPKRm, and smallest for unPKR.  Due to the errant result from 
the PKR-T446 antibody the PKR-T451 antibody from Signal Way was obtained for 
further confirmation of the phosphorylation state of the enzyme.   
 The PKR-T451 antibody was used to produce a new western blot to compare to 
the western blot using the Signal Way phospho-PKR-T446 antibody.  This time T446D 
and eIF2α were used as controls.  The blot using the PKR-T451 antibody should have 
shown strongest bands at T446D and unPKR, instead the strongest bands were seen in the 
pPKRm and pPKRd.  The blot using phospho-PKR-T446 looked plausible. The largest 
band was for pPKRd and the rest of the bands appeared to be background.   
Next, the antibodies that were previously successfully used from Cell Signaling 
Technologies were utilized.  Three western blots were performed with anti-PKR, anti-
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phospho-T451 and anti-phospho-T446 antibodies.  Very bright equivalent bands were 
seen for unPKR, pPKRm, pPKRd, and T446D with all antibodies.   
 The experiments were repeated using freshly made PKR protein and the Cell 
Signaling Technologies antibodies.  The anti-PKR antibody showed equivalent bands for 
all samples as expected.  In the anti-phospho-T451 and anti-phospho-T446 treated blots 
the pPKRm and pPKRd bands were more intense than the bands seen for unPKR and 
T446D.  A trial yielding greater differentiation between bands was needed.   
 Another three westerns using the same “new” protein, and the Cell Signaling 
Technologies antibodies gave the most reasonable results.  Antibody concentration was 
diluted five fold in attempt to make the responsive bands more responsive and the 
background bands less responsive.   
 
Figure 2.  Representative western blot.  The left-handed blot is a control treated with an 
antibody to PKR.  The middle blot is treated with an antibody to phosphorylated T446, 
and the right-handed blot is treated with an antibody to phosphorylated T451.  The 
central and right blots show that T446 and T451 are phosphorylated in pPKRm and 
pPKRd. 
       Un  m  d  446D       un  m   d  446D        un   m   d  446D 
Anti-PKR         Anti-Phospho-T446   Anti-Phospho-T451 
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 To further delineate the reactivity of each band antibody concentration was 
reduced to a 1:20,000 dilution, adding 0.5uL antibody to 10uL primary antibody wash.  
The result is shown in Figure 2.  The left- handed blot treated with anti-PKR showed 
equal bands for all samples.  The central blot treated with anti-phospho-446 showed 
background bands for unPKR and T446D.  Substantial and equal bands were seen for 
pPKRm and pPKRd.  A large band was expected for pPKRd, but it came as a surprise 
that the pPKRm band was equivalent. The right-handed blot treated with anti-phopsho-
T451 showed background bands for unPKR and T446D.  More intense bands were seen 
for pPKRm and pPKRd.  The pPKRm band was more intense than the pPKRd band 
which was unexpected.  Given the overall ambiguity of the antibody reactivity 
throughout the western blots, a single unrepeated trial should not be overanalyzed to 
mean pPKRm is more heavily phosphorylated than pPKRd.  However, this result should 
cause one exhibit caution when making conclusions about the phosphorylation states of 
PKR.   
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Activity Assays 
 
Figure 3.  PKR autophosphorylation assay.  Autophosphorylation of PKR in unPKR, 
pPKRm, pPKRd, and T446D was compared.  Blue represents autophosphorylation in 
unPKR, lavender represents autophosphorylation in pPKRm, purple represents 
autophosphorylation in pPKRd, and turquoise represents autophosphorylation in T446D. 
 
In the first activity assay (Figure 3) the relative activity of unPKR, pPKRm, 
pPKRd, and T446D was compared.  UnPKR, pPKRm, and pPKRd were tested with 
neither dsRNA or eIF2α, as shown in the "neither" lane,  without eIF2α, as seen in the 
"dsRNA" lane, without dsRNA, as seen in the "eIF2α" lane, or with the addition of eIF2α 
and dsRNA as seen in the "both" lane.  The pPKRm and unphosphorylated PKR showed 
similar autophosphorylation results for the addition of dsRNA alone, addition of eIF2a 
alone, the addition of both and the addition of neither.  The reactions containing dsRNA 
and both dsRNA and eIF2α had the most autophosphorylation, while only very low levels 
of autophosphorylation were seen in the reaction with no dsRNA.  In pPKRd, the 
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addition of dsRNA did not impact the level of autophosphorylation which occurred.  
When eIF2α was added the amount of autophosphorylation increased.  T446D showed 
autophosphorylation between the level of unPKR/pPKRm and pPKRd with RNA alone, 
RNA and eIF2α.  
 
Figure 4: eIF2α phosphorylation.  eIF2α phosphorylation by unPKR (blue), pPKRm 
(lavender), pPKRd (purple), and T446D (turquoise).  PPKRd phosphorylated the most 
eIF2α, while the other states phosphorylated about equal amounts of eIF2α. 
  
 During the same activity assay represented in Figure 3 the ability of the different 
forms of PKR to phosphorylate eIF2α was also examined (Figure 4).  The 
phosphorylation of eIF2α by unPKR greatly increased in the presence of dsRNA.  
PPKRm did show an ability to phosphorylate eIF2α, which was slightly lower than the 
ability of unPKR and about half the ability of pPKRd.  The presence of dsRNA did not 
affect the ability of pPKRm to phosphorylate eIF2α.  Overall, pPKRd phosphorylated the 
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greatest amount of eIF2α, and the addition of dsRNA showed a decrease in eIF2α 
phosphorylation.  T446D showed a slightly lower amount of eIF2α phosphorylation than 
pPKRm.   
  
Figure 5. Time course of PKR autophosphorylation.  Time points were taken to 
determine the kinetics of PKR autophosphorylation.  Autophosphorylation happens 
quickly until 0.5 hours, then plateaus until 4 hours, and decreases after 4 hours. 
 
A time course for PKR autophosphorylation using the conditions at which PKR is 
phosphorylated was performed.  The time trial confirmed that the results in Figures 3 and 
4 were from reactions which were allowed to go to completion.  PKR activation 
increased rapidly from 0 minutes until 30 minutes.  From 30 minutes until 4 hours 
activation increased at a much slower rate, and between 4 hours and overnight activation 
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decreased.  The overnight activation decrease came as a surprise and the cause is 
unknown. 
   
  
Figure 6: Autophosphorylation as a function of dsRNA concentration.  
Autophosphorylation of unPKR and pPKRm was examined over a dsRNA concentration 
range from 0-100 ug/mL.  Peak autophosphorylation occurred at 3 ug/mL. 
 
The next activity assay tested the effect of dsRNA concentration on 
autophosphorylation in unPKR and pPKRm (Figure 6).  The experiments showed an 
increase in autophosphorylation with dsRNA concentration until a peak at 3 ug/mL.  The 
slightly greater activation of unPKR is insignificant because in a previous trial (not 
shown) pPKRm had a slightly greater activation.  The cause for the increase in 
autophosphorylation at 100 ug/mL is unknown, and thought to be insignificant.  
Increased autophosphorylation of pPKRm indicated the surprising result that pPKRm can 
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be further phosphorylated.  Also interesting was that the initial activity of pPKRm is not 
zero, most likely because pPKRm is already phosphorylated, and can thus 
autophosphorylate without the addition of dsRNA. 
 
Figure 7: Representative Phosphorimage.  A representative phosphorimage testing the 
activation of unPKR and pPKRm at different dsRNA concentrations.  The bands near the 
top of the gel are PKR which has incorporated radioactive phosphates through 
autophosphorylation.  The bands near the bottom of the gel are eIF2α which has 
incorporated radioactive phosphates. 
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Figure 8:  Autophosphorylation of unPKR and pPKRm as a function of dsRNA 
concentration.  This graph is based on the top row of bands from Figure 7.  PKR 
autophosphorylation is not dependent on dsRNA concentration. 
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Figure 9: eIF2α Phosphorylation by unPKR and pPKRm as a function of dsRNA 
concentration.  This data is from the bottom row of bands in Figure 7.  
Autophosphorylation of both unPKR and pPKRm are not dsRNA dependent.  
 
Next, an analogous experiment was performed, except eIF2α was added.  Figure 7 
is the image of the gel.  The top bands represent PKR which has autophosphorylated, 
incorporating radioactive phosphates.  The bottom bands represent eIF2α with newly 
incorporated radioactive phosphates which unPKR and pPKRm have phosphorylated.  
Figure 8 is an autophosphorylation graph that shows the concentration dependent bell 
curve, in which autophosphorylation of unPKR and pPKRm peaks then decreases at 
higher [RNA], confirming the results of Figure 6.  In the eIF2α phosphorylation graph, 
(Figure 9) unPKR requires dsRNA to phosphorylate eIF2α.  However, after dsRNA has 
been added the eIF2α phosphorylation is not strictly dependent on dsRNA concentration.  
The level of phosphorylation induced by pPKRm is completely independent of dsRNA 
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concentration.  These results represent the first considerable activity difference in unPKR 
and pPKRm.   
 
 
 
 
 
Figure 10.  Comparative activity of pPKRm and pPKRd.  In the top panel the 
autophosphorylation of unPKR (circles), pPKRm (squares), and pPKRd (diamonds) is 
shown.  PPKRm and pPKRd show similar levels of autophosphorylation in the presence 
of RNA.  In the bottom panel the same key is used.  PPKRm and pPKRd show the same 
ability to phosphorylate eIF2α independent of RNA concentration. 
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The next assay was performed to confirm the activation of pPKRd without 
dsRNA, and to compare the activation of unPKR, pPKRm, and pPKRd (Figure 10).  In 
the autophosphorylation graph pPKRm again showed activity by increasing 
autophosphorylation with increased dsRNA concentration.  The active starting point of 
pPKRm at [RNA]=0 was also repeated.  Phosphorylation of eIF2α by pPKRm at 
[RNA]=0 shows pPKRm activity, similar to the activity of  pPKRd at [dsRNA]=0.  The 
eIF2α phosphorylation graph is jumpy for pPKRd, but all data points are within the same 
range, indicating that the amount of RNA is irrelevant for pPKRd phosphorylation of 
eIF2α.   
 
Figure 11: Kinetics of eIF2α phosphorylation.  A time course compared the ability of 
unPKR, pPKRm, and pPKRd to phosphorylate eIF2α.  PPKRd phosphorylated eIF2α the 
fastest.  UnPKR and pPKRm phosphorylated eIF2α to the same terminal level of 
phosphorylation. 
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Next, the kinetics of eIF2α phosphorylation by unPKR, pPKRm and pPKRd were 
examined.  The initial experiment (not shown) indicated that the reaction occurred too 
fast for the rate to be determined.  Therefore the [ATP] was dropped from 400 uM to 40 
uM in the next trial (Figure 11).   The fitting of the data and values in the table were 
obtained as explained in M.9 Radioactive Activity Assays.  In the chart examining eIF2α 
phosphorylation by unPKR, pPKRm and pPKRd pPKRd phosphorylates eIF2α much 
faster that pPKRm, possibly before detection occurred.  The monomer and dimer 
eventually incorporate almost the same amount of phosphates.  A final trial (not shown) 
confirmed that pPKRd activates faster than pPKRm and that the total phosphate 
incorporation on eIF2α reaches similar levels in pPKRm, pPKRd, and unPKR. 
 
 
T446D 
T446 is known to be a conserved residue with involvement in the activation of 
protein kinases [6].  After PKR binds dsRNA, it autophosphorylates T446 which is 
located in the kinase domain.  This autophosphorylation enables dimerization and the 
ability of PKR to phosphorylate eIF2α [16].  The mutant T446D was created to see if 
substitution to a negatively charged residue, aspartic acid, would mimic phosphorylation 
and enable PKR to behave as a dimer.  The negative charge on the phosphate of T446, 
when T446 is phosphorylated creates a salt bridge facilitating dimerization [17] 
To examine the integrity of the proposed hypothesis T446D was used for a variety 
of experiments.  The self-binding property of T446D was assessed by AUC studies.  
T446D was found to have a lower Kd than unPKR and pPKRm (Anderson and Cole, 
unpublished data). T446D was also used as a control for western blots with anti-PKR, 
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anti-phospho-T446, and anti-phospho-T451 antibodies.  As a control, bands were 
expected to be seen in the anti-PKR treated blot for T446D, and no bands were expected 
to be seen for T446D in the anti-phospho-T446 and anti-phospho-T451 treated blots.   
 After the AUC and western blot experiments it was concluded that the proposed 
substitution of a phosphate by an aspartic acid was unsuccessful.  Closer behavior of 
T446D to pPKRm than even unPKR was unexpected.  However, point mutations have 
been known to change protein characteristics in unsuspected ways.  For example, the 
T446D mutant was extremely difficult to concentrate due to high aggregation.   
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Discussion 
 Distinct dimerization and structural differences between pPKRm and pPKRd have 
been identified (Anderson and Cole, unpublished data).  The experiments outlined in the 
thesis provide insight into the activation differences between the two phosphorylated 
states.  Western blots and a point mutant were used to examine the phosphorylation of 
essential residues.  Activity assays attacked the activation problem by a comparative 
analysis of autophosphorylation and eIF2α phosphorylation by pPKRm and pPKRd. 
The anti-phospho-T446 and anti-phospho-T451 blots showed about equal reaction 
for both pPKRm and pPKRd.  Therefore, the western blots could not be used to confirm 
the hypothesis that phosphorylation of T446 or T451 did not occur on pPKRm.  The 
seemingly equal reactivity is most likely due to a lack of specificity of the antibodies.  
Therefore, western blots could not be used to determine the phosphorylation states of 
T446 and T451 in pPKRm and pPKRd . 
 The most information was extracted from the phosphorylation measurements.  
Over several trials it was shown that autophosphorylation is dsRNA dependent in unPKR 
and pPKRm, with an optimum dsRNA concentration around 3-10ug/mL.  However, at 
[dsRNA] = 0, unPKR has no autophosphorylation and pPKRm exhibits a small amount.  
Autophosphorylation in pPKRd also showed no dsRNA dependence.  The dsRNA 
independent autophosphorylation is most likely because pPKRd is dimerized and 
phosphorylated, so it is already active and therefore able to autophosphorylate.  The 
dsRNA independent autophosphorylation in pPKRm indicates that pPKRm is an active 
enzyme.   
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Examination of the phosphorylation of eIF2α by the three populations confirmed 
the activity of pPKRm.  PPKRm and pPKRd showed similar amounts of eIF2α 
phosphorylation, independent of dsRNA concentration.  It can be deduced that only a 
small amount of autophosphorylation needs to occur in order for PKR to phosphorylate 
eIF2α because despite an increased amount of autophosphorylation in pPKRd the same 
level of eIF2α phosphorylation was observed by both pPKRm and pPKRd.  Since the 
purpose of PKR autophosphorylation is eIF2α phosphorylation, it is possible that both 
pPKRm and pPKRd contribute to PKR activity in the cell.   
Kinetic studies revealed pPKRd phosphorylates eIF2α much faster than pPKRm.  
This may give reasoning for the utilization of the phosphodimer over the 
phosphomonomer.  However, both pPKRm and pPKRd will eventually phosphorylate 
about the same amount of eIF2α, further enhancing the possibility of pPKRm 
contribution to overall PKR activity in the cell. 
 By column elution and analytical ultracentrifugation T446D identified more 
closely with pPKRm than pPKRd.  Sedimentation velocity analytical ultracentrifugation 
of T446D showed less dimerization in T446D than in unPKR, pPKRm and pPKRd.  This 
is most likely due to the inability of aspartic acid to act as a phosphate, not confirmation 
that phosphorylation of T446 has no effect on dimerization. 
 The data showed that pPKRm is an active state with activation potential similar to 
pPKRd in its ability to autophosphorylate with appropriate dsRNA and the ability to 
phosphorylate eIF2α.  The differences in the rate of pPKRm and pPKRd phosphorylation 
of eIF2α point to a difference in the activation mechanism of pPKRm and pPKRd.  My 
preliminary idea for the difference in pPKRm and pPKRd formation is that two 
  
34 
unphosphorylated PKR molecules bind to dsRNA which orients them for 
autophosphorylation and dimerization.  After the phosphorylated dimer is released there 
is a one time irreversible disassociation in one portion of the population resulting in the 
phosphorylated monomer.  The unpublished Anderson data suggests that pPKRm is less 
phosphorylated than pPKRd.  The most obvious biological significance in having two 
distinct populations is the increased speed at which pPKRd can phosphorylate eIF2α.  
The increased phosphorylation of pPKRd results in an increased negative charge on the 
PKR.  An increased negative charge could provide a stronger attraction between the 
Ser51 on eIF2α and PKR leading to a faster reaction for eIF2α phosphorylation. 
In conclusion, pPKRm is a competent, active form of PKR.  The biological 
significance of the existence of two forms lies in the difference in activation rates.  
Although the data could not support a conclusive model for the formation of two distinct 
phosphorylated populations or provide decisive data for the biological significance of the 
existence of two populations, supportive evidence has been found and used to create 
preliminary models. 
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